Efficacy Outcome Measures of Oral Ponesimod Compared to Teriflunomide in Patients with Relapsing Multiple Sclerosis: Results of the Randomized, Active-Controlled, Double-Blind, Parallel-Group Phase 3 OPTIMUM Study

被引：0

作者：

Fox, Robert ^{[1
]}

Kappos, Ludwig ^{[2
,3
,4
,5
]}

Burcklen, Michel ^{[6
]}

Freedman, Mark ^{[7
,8
]}

Havrdova, Eva ^{[9
]}

Hennessy, Brian ^{[6
]}

Hohlfeld, Reinhard ^{[10
]}

Lublin, Fred ^{[11
]}

Montalban, Xavier ^{[12
,13
]}

Pozzilli, Carlo ^{[14
]}

Scherz, Tatiana ^{[6
]}

Linscheid, Philippe ^{[6
]}

Pirozek-Lawniczek, Magdalena ^{[6
]}

Kracker, Hilke ^{[6
]}

Sprenger, Till ^{[2
,3
,4
,5
,15
]}

机构：

[1] Cleveland Clin, Cleveland, OH 44106 USA

[2] Univ Hosp Basel, Neurol Clin & Policlin, Dept Med, Basel, Switzerland

[3] Univ Hosp Basel, Neurol Clin & Policlin, Dept Clin Res, Basel, Switzerland

[4] Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland

[5] Univ Hosp Basel, Neurol Clin & Policlin, Dept Biomed Engn, Basel, Switzerland

[6] Actel Pharmaceut Ltd, Allschwil, Switzerland

[7] Univ Ottawa, Ottawa, ON, Canada

[8] Ottawa Hosp Res Inst, Ottawa, ON, Canada

[9] Charles Univ Prague, Prague, Czech Republic

[10] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, Munich, Germany

[11] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[12] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada

[13] Vall dHebron Univ Hosp, Multiple Sclerosis Ctr Catalonia, Barcelona, Spain

[14] Sapienza Univ Rome, S Andrea MS Ctr, Rome, Italy

[15] DKD HELIOS Klin Wiesbaden, Wiesbaden, Germany

来源：

NEUROLOGY | 2020年 / 94卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

3972

引用

页数：5

共 50 条

[21] Efficacy and safety of Diclofenac sodium plaster in patients with acute pain of the limbs: a randomized, placebo and active-controlled, double-blind, parallel-group trial
Pabst, H.
Gruber, G.
Picciotto, R.
Barbaro, B.
Giordan, N.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (07) : 3181 - 3190
[22] Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a 3-adrenoceptor agonist, in patients with overactive bladder in Asia
Kuo, Hann-Chorng
Lee, Kyu-Sung
Na, Yanqun
Sood, Rajeev
Nakaji, Shigeru
Kubota, Yosuke
Kuroishi, Kentarou
NEUROUROLOGY AND URODYNAMICS, 2015, 34 (07) : 685 - 692
[23] MIN-117: a randomized, double-blind, parallel-group, placebo- and active-controlled study in patients with major depressive disorder
Davidson, M.
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S785 - S785
[24] A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled Study to Evaluate the Efficacy and Safety of MIN-117 in Patients With Major Depressive Disorder
Davidson, Michael
Staner, Corinne
Saoud, Jay
Noel, Nadine
Werner, Sandra
Luthringer, Elisabeth
Reilly, Joe
Luthringer, Remy
NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S370 - S370
[25] Randomized, Double-Blind, Active-Controlled Phase 3 Study to Evaluate Efficacy and Safety of Zastaprazan Compared With Esomeprazole in Erosive Esophagitis
Oh, Jung-Hwan
Kim, Hyun-Soo
Cheung, Dae Young
Lee, Hang Lak
Lee, Dong Ho
Kim, Gwang Ha
Choi, Suck Chei
Cho, Yu Kyung
Chung, Woo Chul
Kim, Ji Won
Yu, Eunju
Kwon, Hyesoo
Kim, Jun
Kim, John
Jung, Hwoon-Yong
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2025, 120 (02): : 353 - 361
[26] Efficacy of Ozanimod Versus Interferon β-1a by Prior Treatment and Baseline Disability in Two Multicenter, Randomized, Double-Blind, Parallel-Group, Active-Controlled, Double-Dummy Phase 3 Studies in Relapsing Multiple Sclerosis (SUNBEAM and RADIANCE Part B)
Kappos, Ludwig
Selmaj, Krzysztof
Bar-Or, Amit
Comi, Giancarlo
Arnold, Douglas
Steinman, Lawrence
Hartung, Hans-Peter
Montalban, Xavier
Havrdova, Eva
Sheffield, James
Raghupathi, Kartik
Cree, Bruce
Cohen, Jeffrey
NEUROLOGY, 2018, 90
[27] Efficacy and Safety of SID142 in Patients With Peripheral Arterial Disease: A Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group, Phase III Clinical Trial
Kook, Hyungdon
Yu, Cheol Woong
Choi, Donghoon
Ahn, Tae Hoon
Chang, Kiyuk
Cho, Jin-Man
Kim, Soo-Joong
Park, Chang Gyu
Cho, Deok-Kyu
Kim, Sang-Hyun
Lee, Han Cheol
Jin, Han-Young
Chae, In-Ho
Kwon, Kihwan
Ahn, Sung Gyun
Kim, Ju Han
Lee, Sang-Rok
Kim, Jeong-Su
Kim, Seok Yeon
Lim, Sang Wook
CLINICAL THERAPEUTICS, 2022, 44 (04) : 508 - +
[28] Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One) a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study
Brown, J. William L.
Cunniffe, Nick G.
Prados, Ferran
Kanber, Baris
Jones, Joanne L.
Needham, Edward
Georgieva, Zoya
Rog, David
Pearson, Owen R.
Overell, James
MacManus, David
Samson, Rebecca S.
Stutters, Jonathan
Ffrench-Constant, Charles
Wheeler-Kingshott, Claudia A. M. Gandini
Moran, Carla
Flynn, Paul D.
Michell, Andrew W.
Franklin, Robin J. M.
Chandran, Siddharthan
Altmann, Daniel R.
Chard, Declan T.
Connick, Peter
Coles, Alasdair J.
LANCET NEUROLOGY, 2021, 20 (09): : 709 - 720
[29] Efficacy and tolerability of oral budesonide in Japanese patients with active Crohn's disease: A multicentre, double-blind, randomized, parallel-group Phase II study
Suzuki, Yasuo
Motoya, Satoshi
Takazoe, Masakazu
Kosaka, Tadashi
Date, Masataka
Nii, Masahiro
Hibi, Toshifumi
JOURNAL OF CROHNS & COLITIS, 2013, 7 (03): : 239 - 247
[30] Efficacy and Safety of FospropofolFD Compared to Propofol When Given During the Induction of General Anaesthesia: A Phase II, Multi-centre, Randomized, Parallel-Group, Active-Controlled, Double-Blind, Double-Dummy Study
Liu, Rong
Luo, Chaozhi
Liu, Jin
Zhang, Wensheng
Li, Yan
Xu, Jing
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2016, 119 (01) : 93 - 100

← 1 2 3 4 5 →